Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Naunyn Schmiedebergs Arch Pharmacol ; 312(3): 285-91, 1980 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7402370

RESUMO

Pretreatment of rats with (+)cyanidanol--3 decreases the alterations in liver function tests (transaminase and bilirubin) as well as the accumulation of hepatic triglycerides induced by acute doses of galactosamine or carbon tetrachloride. This action was related to the dose of (+)cyanidanol-3 administered. The lowest effective doses were 3 intraperitoneal injections of 125 mg/kg administered before galactosamine or carbon tetrachloride. In the case of carbon tetrachloride intoxication, in vivo administration of (+)cyanidanol-3 reduced to a slight extent the absorption of conjugated dienes produced in liver microsomal lipid. This observation confirms that (+)cyanidanol-3 is able to prevent lipid peroxidation in vivo. As the protective effect of (+)cyanidanol-3 becomes apparent in two types of intoxication which are very different in their primary mechanisms of action, it is suggested that, the flavonoid also acts on a later stage of the process leading to necrosis and steatosis of the liver.


Assuntos
Benzopiranos/farmacologia , Intoxicação por Tetracloreto de Carbono/prevenção & controle , Catequina/farmacologia , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Galactosamina/intoxicação , Animais , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Peróxidos Lipídicos/metabolismo , Testes de Função Hepática , Masculino , Ratos , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...